In this podcast, Natalie D. Crawford, PhD, discusses the results of her team's recent study examining the potential benefits of pharmacy integration in increasing access and use of preexposure prophylaxis...
In this podcast, Jeffrey Kwong, DNP, MPH, ANP-BC, discusses the use of HIV pre-exposure prophylaxis (PrEP) in older adults, its safety and efficacy in this patient population, and what barriers exist for...
In this expert interview, Melissa E. Badowski, PharmD, MPH, provides an overview of her presentation at IDWeek 2023 titled, "Guideline Adherence to Hepatitis B Virus Screening and Vaccination in Patients...
In this interview, Jessica Rodrigues, MS, answers questions about barriers to the access of pre-exposure prophylaxis (PrEP), funding, stigma, and choices of PrEP. She also spoke about these topics during...
In this podcast, Jessica Rodrigues, with AVAC: Global Advocacy for HIV Prevention, speaks about ways communities can overcome barriers to the access of pre-exposure prophylaxis (PrEP), including ambitious...
In this podcast, Jessica Rodrigues, with AVAC: Global Advocacy for HIV Prevention, provides a description of a Dual Prevention Pill and why it can be used as a case study for future multipurpose...
PrEP has become more mainstream in the media, and the USPSTF recently recommended PrEP for all at-risk populations. Richard Chaisson, MD, shines light on these at-risk populations.
In this short video, Jordan Feld, MD, MPH, talks about his team's latest research on hepatitis C virus infections among patients taking pre-exposure prophylaxis for HIV infection.
In this Q&A, Monica Gandhi, MD, MPH, discusses interventions to address the health care disparities that exist along the care continuum for certain patient populations who are at-risk for HIV...
Monica Gandhi, MD, MPH, infectious disease doctor and director of the Center for AIDS Research at University of California–San Francisco, discusses medication therapies in the pipeline that could change the...
